The strengths of our study include demonstrating that plasma DKK-1 levels are inversely correlated with the eGFR and that the Wnt/β-catenin signaling pathway may be involved in the underlying mechanism of CKD in patients without known DM. This evidence concerns the gene DKK1 and diabetes mellitus.